BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18562629)

  • 1. The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.
    Mabley JG; Pacher P; Murthy KG; Williams W; Southan GJ; Salzman AL; Szabo C
    J Endocrinol; 2008 Sep; 198(3):581-9. PubMed ID: 18562629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.
    Mabley JG; Rabinovitch A; Suarez-Pinzon W; Haskó G; Pacher P; Power R; Southan G; Salzman A; Szabó C
    Mol Med; 2003; 9(3-4):96-104. PubMed ID: 12865945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury.
    Mabley JG; Pacher P; Murthy KG; Williams W; Southan GJ; Salzman AL; Szabo C
    Shock; 2009 Sep; 32(3):258-62. PubMed ID: 19174745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine reduces the incidence of type I diabetes in mice.
    Mabley JG; Pacher P; Southan GJ; Salzman AL; Szabó C
    J Pharmacol Exp Ther; 2002 Mar; 300(3):876-81. PubMed ID: 11861793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetes.
    Tekula S; Khurana A; Anchi P; Godugu C
    Biomed Pharmacother; 2018 Oct; 106():1428-1440. PubMed ID: 30119216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Resolution of Diabetes: C-C Chemokine Motif Ligand 4 Is a Common Target in Different Types of Diabetes by Protecting Pancreatic Islet Cell and Modulating Inflammation.
    Chang TT; Lin LY; Chen JW
    Front Immunol; 2021; 12():650626. PubMed ID: 33968046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
    Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
    Mabley JG; Southan GJ; Salzman AL; Szabó C
    Pancreas; 2004 Mar; 28(2):E39-44. PubMed ID: 15028959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
    Stosic-Grujicic S; Cvetkovic I; Mangano K; Fresta M; Maksimovic-Ivanic D; Harhaji L; Popadic D; Momcilovic M; Miljkovic D; Kim J; Al-Abed Y; Nicoletti F
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1038-49. PubMed ID: 17148780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P; Ji RC; Shimoda H; Miura M; Kato S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
    Bianchi MS; Bianchi S; Hernado-Insúa A; Martinez LM; Lago N; Libertun C; Chasseing NA; Montaner AD; Lux-Lantos VA
    Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E380-95. PubMed ID: 27329801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of wax apple (Syzygium samarangense (Blume) Merr. & L.M. Perry) against streptozotocin-induced pancreatic ß-cell damage in diabetic rats.
    Khamchan A; Paseephol T; Hanchang W
    Biomed Pharmacother; 2018 Dec; 108():634-645. PubMed ID: 30245463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antidiabetic activity of polysaccharide isolated from Phellinus linteus in non-obese diabetic mouse.
    Kim HM; Kang JS; Kim JY; Park SK; Kim HS; Lee YJ; Yun J; Hong JT; Kim Y; Han SB
    Int Immunopharmacol; 2010 Jan; 10(1):72-8. PubMed ID: 19811769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.
    Brill AL; Wisinski JA; Cadena MT; Thompson MF; Fenske RJ; Brar HK; Schaid MD; Pasker RL; Kimple ME
    Mol Endocrinol; 2016 May; 30(5):543-56. PubMed ID: 27049466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone can prevent development of type 1 diabetes induced by multiple low-dose streptozotocin in mice.
    Ogawa J; Takahashi S; Fujiwara T; Fukushige J; Hosokawa T; Izumi T; Kurakata S; Horikoshi H
    Life Sci; 1999; 65(12):1287-96. PubMed ID: 10503944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice.
    Weiss L; Bernstein S; Jones R; Amunugama R; Krizman D; Jebailey L; Almogi-Hazan O; Yekhtin Z; Shiner R; Reibstein I; Triche E; Slavin S; Or R; Barnea ER
    Endocrine; 2011 Aug; 40(1):41-54. PubMed ID: 21424847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice.
    Yang Z; Chen M; Fialkow LB; Ellett JD; Wu R; Nadler JL
    Pancreas; 2003 May; 26(4):e99-104. PubMed ID: 12717280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of carbonyl iron against multiple low-dose streptozotocin-induced diabetes in rodents.
    Vujicic M; Saksida T; Mostarica Stojkovic M; Djedovic N; Stojanovic I; Stosic-Grujicic S
    J Cell Physiol; 2018 Jun; 233(6):4990-5001. PubMed ID: 29215791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual genetic absence of STAT6 and IL-10 does not abrogate anti-hyperglycemic effects of Schistosoma mansoni in streptozotocin-treated diabetic mice.
    Osada Y; Fujiyama T; Kamimura N; Kaji T; Nakae S; Sudo K; Ishiwata K; Kanazawa T
    Exp Parasitol; 2017 Jun; 177():1-12. PubMed ID: 28363777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.
    Müller A; Schott-Ohly P; Dohle C; Gleichmann H
    Immunobiology; 2002 Mar; 205(1):35-50. PubMed ID: 11999343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.